Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
Tatsuya FukudaRyotaro BouchiTakato TakeuchiKazutaka TsujimotoIsao MinamiTakanobu YoshimotoYoshihiro OgawaPublished in: Cardiovascular diabetology (2018)
The present data suggest that the whole body DXA is valuable in the diagnosis of sarcopenic obesity (high A/G ratio or android fat mass with low SMI) to determine the risk of CVD events in patients with type 2 diabetes. Meanwhile, sarcopenic obesity classified with low SMI, and high %BF or BMI was not associated with incident CVD.
Keyphrases
- dual energy
- computed tomography
- cardiovascular disease
- insulin resistance
- metabolic syndrome
- weight loss
- weight gain
- type diabetes
- image quality
- high fat diet induced
- adipose tissue
- contrast enhanced
- body mass index
- body composition
- magnetic resonance imaging
- cardiovascular events
- electronic health record
- physical activity
- high resolution